Soleno Therapeutics, Inc. (SLNO)

NASDAQ

$--

(--)

After-Hours

Soleno Therapeutics, Inc. (SLNO) Live Price Chart

Last updated: ⁦2026-10-13 23:34:40⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Soleno Therapeutics, Inc. (SLNO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Soleno Therapeutics, Inc. (SLNO) After-Hours Stock Price

Soleno Therapeutics, Inc. (SLNO) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.

After-hours trading shows how investors are pricing SLNO after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.

Soleno Therapeutics, Inc. (SLNO) 7-Day Stock Price Change

Over the past seven days, Soleno Therapeutics, Inc. (SLNO) moved from $52.94 to $53.01, representing a gain of 0.13% ($0.07).

The stock traded between $52.91 and $53.01 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 2.08 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Soleno Therapeutics, Inc. (SLNO)?

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. The company's reporting segment focused on the development and commercialization of its sole therapeutic product, VYKAT XR.

Soleno Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	182
Exchange	NASDAQ
Company Website	https://www.soleno.life

How to Buy Soleno Therapeutics, Inc. (SLNO) Stock on MEXC

Eligible investors can buy real shares of Soleno Therapeutics, Inc. (SLNO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SLNO and Place Your Order

Open the RealStocks trading page and search for SLNO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Soleno Therapeutics, Inc. (SLNO) stock price today?

Soleno Therapeutics, Inc. (SLNO) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is SLNO stock going up or down today?

As of --, SLNO is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is SLNO pre-market price?

As of --, SLNO is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SLNO after-hours price?

As of --, SLNO is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SLNO stock trading now?

SLNO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SLNO sit relative to its 52-week high and low?

Over the past 52 weeks, SLNO has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Soleno Therapeutics, Inc. in?

Soleno Therapeutics, Inc. (SLNO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Soleno Therapeutics, Inc.'s market capitalization and where is it listed?

Soleno Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SLNO valued in terms of P/E ratio and EPS?

SLNO trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Soleno Therapeutics, Inc. pay a dividend?

Soleno Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.